Kenneth Newman, M.D.Vice President, Clinical Development at Ionis Pharmaceuticals
Agenda Sessions
Antisense Oligonucleotide Therapy to Pre-kallikrein in the Treatment of Patients with Hereditary Angioedema (HAE)
, 5:15pmView Session